Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for perioperative sedation during percutaneous tracheostomy in neurocritical patients
ChiCTR2500102111Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in traumatic brain injury (TBI), stroke and brain neoplasm (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Incidence of hypotension. Started May 2025; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
traumatic brain injury (TBI)strokebrain neoplasm
Beyond the preview
Go deeper on ChiCTR2500102111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102111.